Begin main content

Reports

We found 5312 result(s)

ledipasvir, sofosbuvir (Harvoni)

Last Updated: May 23, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: ledipasvir, sofosbuvir
Indications: Hepatitis C, chronic

  • Brand Name: Harvoni
  • Manufacturer: Gilead Sciences Canada Inc.
  • Project Number: SF0465-000
  • Project Status: Complete
  • Submission Type: RequestForAdvice

Tags

Hepatitis C, Hepatitis

Daptomycin for Vancomycin-Resistant Enterococcal Infection: A Review of the Clinical Effectiveness, Cost-Effectiveness and Guidelines

Published on: January 14, 2016
Result type: Reports
Product Line: Rapid Response
Research Type: Drug

  • Project Number: RC0738-000

Tags

Cubicin, Daptomycin, Vancomycin Resistance, Antibiotic resistant organisms, Cost-Effectiveness and Guidelines, Daptomycin for Vancomycin-Resistant Enterococcal Infection: A Review of the Clinical Effectiveness, VRE, Vancomycin-resistant Enterococcus, enterococci, vancomycin resistant enterococci, vancomycin-resistant enterococci

Selexipag (Uptravi)

Last Updated: February 16, 2016
Result type: Reports
Product Line: Common Drug Review
Generic Name: Selexipag
Indications: Pulmonary arterial hypertension (WHO class II and III)

  • Brand Name: Uptravi
  • Manufacturer: Actelion Pharmaceuticals Canada Inc.
  • Project Number: SR0482-000
  • Project Status: Complete
  • Submission Type: New

High-Sensitivity Cardiac Troponin for the Rapid Diagnosis of Acute Coronary Syndrome in the Emergency Department: A Clinical and Cost-Effectiveness Evaluation

Published on: June 24, 2013
Result type: Reports
Product Line: Health Technology Assessment, CADTH Technology Overviews

Adapted from Canadian Agency for Drugs and Technologies in Health. High-Sensitivity Cardiac Troponin for the Rapid Diagnosis of Acute Coronary Syndrome in the Emergency Department: A Clinical and Cost-Effectiveness Evaluation (Optimal Use Report). Ottawa: Canadian Agency for Drugs and Technologies in Health; 2013. Introduction Acute coronary syn...